Another vaccine has been registered by Turkmenistan - EpiVacCoronapatented by the State Research Center of Virology and Biotechnology "Vector (Novosibirsk, Russian Federation). Thus, Turkmenistan is the first state to register the drug after the direct manufacturer, Russia.
The Center for Registration of Medicines and State Control under the Ministry of Health of Turkmenistan issued a certificate After expert analysis by the committees of the Center on pharmacology and pharmacopeia.
Obtaining a certificate makes it possible to purchase and use the drug in Turkmenistan for preventive purposes against viral diseases.
EpiWakKorona underwent registration in the Russian Federation in the fall of 2020 and also underwent post-registration clinical trials.
Previously Turkmenistan was the first in Central Asia to register the Sputnik V vaccine Russian-made.